Addressing the Burden of Group A Streptococcal Disease in India

Anita Shet, Edward Kaplan

Research output: Contribution to journalReview article

Abstract

Group A streptococcus-associated disease and sequelae continue to have devastating effects on public health and national economy as they mainly affect children and young adults. There is an urgent need for wider application of methods of primary prevention, in the form of optimal diagnosis and management of the simple group A streptococcal sore throat. This review article briefly summarizes the burden of streptococcal disease in India, and discusses treatment options standardized by the World Health Organization. Penicillin continues to remain the drug of choice for treating group A streptococcal pharyngitis and for prevention of acute rheumatic fever in non-allergic patients. Also discussed in this review are contemporary thoughts on streptococcal "carriers", recurrent infections, antibiotic treatment "failures" and emergence of drug resistance among group A streptococci.

Original languageEnglish (US)
Pages (from-to)41-48
Number of pages8
JournalIndian Journal of Pediatrics
Volume71
Issue number1
StatePublished - Jan 2004
Externally publishedYes

Fingerprint

Pharyngitis
Streptococcus
India
Rheumatic Fever
Primary Prevention
Treatment Failure
Drug Resistance
Penicillins
Young Adult
Public Health
Anti-Bacterial Agents
Infection
Pharmaceutical Preparations
Therapeutics

Keywords

  • Group A streptococcus
  • Management
  • Penicillin
  • Pharyngitis
  • Rheumatic fever

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Addressing the Burden of Group A Streptococcal Disease in India. / Shet, Anita; Kaplan, Edward.

In: Indian Journal of Pediatrics, Vol. 71, No. 1, 01.2004, p. 41-48.

Research output: Contribution to journalReview article

@article{a18af5c397054501a5041823c6855815,
title = "Addressing the Burden of Group A Streptococcal Disease in India",
abstract = "Group A streptococcus-associated disease and sequelae continue to have devastating effects on public health and national economy as they mainly affect children and young adults. There is an urgent need for wider application of methods of primary prevention, in the form of optimal diagnosis and management of the simple group A streptococcal sore throat. This review article briefly summarizes the burden of streptococcal disease in India, and discusses treatment options standardized by the World Health Organization. Penicillin continues to remain the drug of choice for treating group A streptococcal pharyngitis and for prevention of acute rheumatic fever in non-allergic patients. Also discussed in this review are contemporary thoughts on streptococcal {"}carriers{"}, recurrent infections, antibiotic treatment {"}failures{"} and emergence of drug resistance among group A streptococci.",
keywords = "Group A streptococcus, Management, Penicillin, Pharyngitis, Rheumatic fever",
author = "Anita Shet and Edward Kaplan",
year = "2004",
month = "1",
language = "English (US)",
volume = "71",
pages = "41--48",
journal = "Indian Journal of Practical Pediatrics",
issn = "0972-9607",
publisher = "Springer India",
number = "1",

}

TY - JOUR

T1 - Addressing the Burden of Group A Streptococcal Disease in India

AU - Shet, Anita

AU - Kaplan, Edward

PY - 2004/1

Y1 - 2004/1

N2 - Group A streptococcus-associated disease and sequelae continue to have devastating effects on public health and national economy as they mainly affect children and young adults. There is an urgent need for wider application of methods of primary prevention, in the form of optimal diagnosis and management of the simple group A streptococcal sore throat. This review article briefly summarizes the burden of streptococcal disease in India, and discusses treatment options standardized by the World Health Organization. Penicillin continues to remain the drug of choice for treating group A streptococcal pharyngitis and for prevention of acute rheumatic fever in non-allergic patients. Also discussed in this review are contemporary thoughts on streptococcal "carriers", recurrent infections, antibiotic treatment "failures" and emergence of drug resistance among group A streptococci.

AB - Group A streptococcus-associated disease and sequelae continue to have devastating effects on public health and national economy as they mainly affect children and young adults. There is an urgent need for wider application of methods of primary prevention, in the form of optimal diagnosis and management of the simple group A streptococcal sore throat. This review article briefly summarizes the burden of streptococcal disease in India, and discusses treatment options standardized by the World Health Organization. Penicillin continues to remain the drug of choice for treating group A streptococcal pharyngitis and for prevention of acute rheumatic fever in non-allergic patients. Also discussed in this review are contemporary thoughts on streptococcal "carriers", recurrent infections, antibiotic treatment "failures" and emergence of drug resistance among group A streptococci.

KW - Group A streptococcus

KW - Management

KW - Penicillin

KW - Pharyngitis

KW - Rheumatic fever

UR - http://www.scopus.com/inward/record.url?scp=1142286476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1142286476&partnerID=8YFLogxK

M3 - Review article

C2 - 14979385

AN - SCOPUS:1142286476

VL - 71

SP - 41

EP - 48

JO - Indian Journal of Practical Pediatrics

JF - Indian Journal of Practical Pediatrics

SN - 0972-9607

IS - 1

ER -